VCYT FY 2021 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$220M+86.8% YoY

Gross Profit

$145M66.1% margin

Operating Income

-$82M-37.3% margin

Net Income

-$76M-34.4% margin

EPS (Diluted)

$-1.11

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$37M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$91M

Stockholders' Equity

$1.1B

Cash & Equivalents

$173M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$220M	$117M	+86.8%
Gross Profit	$145M	$76M	+90.9%
Operating Income	-$82M	-$35M	-131.4%
Net Income	-$76M	-$35M	-116.5%